Home › Funds › Boston Partners › LH

Boston Partners position in LH

LABCORP HOLDINGS INC · Health Care

Boston Partners reported holding 2,948,535 shares of LH (LABCORP HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$908.7M, representing 0.82% of its reported portfolio and ranking #31 among its reported holdings. Boston Partners has disclosed LH holdings in 5 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)2.95M sh
Reported value held$908.74M
Portfolio Weight0.82%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Boston Partners's LH position evolved

Boston Partners first disclosed a stake in LH in Q3 2023 at 418,995 shares (US$84.2M). The position peaked in Q3 2026 at 2,948,535 shares, worth US$908.7M. Across 5 filings, Boston Partners increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,948,535 shares valued at US$908.7M — a reduction of -103,155 shares quarter over quarter.. Notable position changes include a 29% increase in Q2 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 419.00K $84.24M New
Q4 2025 1.91M $480.27M New
Q1 2026 2.37M $632.42M Add
Q2 2026 3.05M $854.20M Add
Q3 2026 2.95M $908.74M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LH and 13F data

LH (LABCORP HOLDINGS INC) is a Health Care company. 26 other funds we track also report a position in LH — the largest reported positions include VICTORY CAPITAL MANAGEMENT INC (US$1.21B), Allspring Global Investments Holdings, LLC (US$632.2M), Select Equity Group, L.P. (US$554.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LH

All LH fund holders →

FAQ

How long has Boston Partners held LH?

Boston Partners has disclosed LH holdings in 5 of the last 13 reported quarters, going back to Q3 2023.

What is Boston Partners's current position in LH?

As of Q3 2026, Boston Partners holds 2.95M shares of LH (LABCORP HOLDINGS INC), valued at $908.74M, representing 0.82% of its reported portfolio and ranking #31.

Has Boston Partners been buying or selling LH?

In the latest 13F filing (Q3 2026), Boston Partners reduced its position in LH. The position peaked in Q3 2026 at 2.95M shares.

Which other funds hold LH?

Other major institutional holders of LH include VICTORY CAPITAL MANAGEMENT INC, Allspring Global Investments Holdings, LLC, Select Equity Group, L.P., among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.